Concepedia

Ágnes Benedict

ÁB

19

Publications

712

Citations

17

H-Index

2004

Active since

Affiliations

United BioSource Corporation (United Kingdom)(Current)

Research Triangle Park Foundation

University of Sheffield

Harvard University

The University of Texas Southwestern Medical Center

Ágnes Benedict is an author at United BioSource Corporation (United Kingdom) specializing in medicine, oncology, and outcomes research.

ORCID

Top concepts

Publications per year

2004–2020

19

Publications

19

Simulation and Matching-Based Approaches for Indirect Comparison of Treatments

K. Jack Ishak, Irina Proskorovsky, Ágnes Benedict · PharmacoEconomics · 2015 · 103 citations

, , +8

INCIDENCE-BASED COST-OF-ILLNESS MODEL FOR METASTATIC BREAST CANCER IN THE UNITED STATES

Sonja Sorensen, Jo Wern Goh, Feng Pan et al. · International Journal of Technology Assessment in Health Care · 2012 · 71 citations

Treatment costs of prostate cancer in the first year after diagnosis: a short‐term cost of illness study for France, Germany, Italy, Spain and the UK

R. Fourcade, Ágnes Benedict, Libby Black et al. · British Journal of Urology · 2009 · 68 citations

Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective

Andrzej Jakubowiak, Marco Campioni, Ágnes Benedict et al. · Journal of Medical Economics · 2016 · 51 citations · Full text

Economic evaluation of new targeted therapies for the first‐line treatment of patients with metastatic renal cell carcinoma

Ágnes Benedict, Robert A. Figlin, Per Sandström et al. · British Journal of Urology · 2011 · 45 citations

Rows per page

1–5 of 19